Advanced search

Efficacy and safety of Rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Preliminary results of a multicenter, open label, phase II trial (M39037 TRIAL)

(2002) BLOOD. 100(11).
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
CHOQUET, S, R HERBRECHT, G SOCIE, AM STOPPA, P VANDENBERGHE, W FEREMENS, A FISCHER, et al. 2002. “Efficacy and Safety of Rituximab in B-cell Post Transplantation Lymphoproliferative Disorders (B-PTLD): Preliminary Results of a Multicenter, Open Label, Phase II Trial (M39037 TRIAL).” In Blood, 100:467. AMER SOC HEMATOLOGY.
APA
CHOQUET, S., HERBRECHT, R., SOCIE, G., STOPPA, A., VANDENBERGHE, P., FEREMENS, W., FISCHER, A., et al. (2002). Efficacy and safety of Rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Preliminary results of a multicenter, open label, phase II trial (M39037 TRIAL). BLOOD (Vol. 100, p. 467). AMER SOC HEMATOLOGY.
Vancouver
1.
CHOQUET S, HERBRECHT R, SOCIE G, STOPPA A, VANDENBERGHE P, FEREMENS W, et al. Efficacy and safety of Rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Preliminary results of a multicenter, open label, phase II trial (M39037 TRIAL). BLOOD. AMER SOC HEMATOLOGY; 2002. p. 467.
MLA
CHOQUET, S, R HERBRECHT, G SOCIE, et al. “Efficacy and Safety of Rituximab in B-cell Post Transplantation Lymphoproliferative Disorders (B-PTLD): Preliminary Results of a Multicenter, Open Label, Phase II Trial (M39037 TRIAL).” Blood. Vol. 100. AMER SOC HEMATOLOGY, 2002. 467. Print.
@inproceedings{308454,
  author       = {CHOQUET, S and HERBRECHT, R and SOCIE, G and STOPPA, AM and VANDENBERGHE, P and FEREMENS, W and FISCHER, A and MORSCHAUSER, F and SALLES, G and VILMER, E and GARNIER, JL and JACCARD, A and LAMY, T and LANG, P and LEBRANCHU, Y and Offner, Fritz and OKSENHENDLER, E and IMADALOU, K and FAFI, S and MOREAU, A and LEBLOND, V and MILPIED, N},
  booktitle    = {BLOOD},
  issn         = {0006-4971},
  language     = {eng},
  number       = {11},
  pages        = {467A-467A},
  publisher    = {AMER SOC HEMATOLOGY},
  title        = {Efficacy and safety of Rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Preliminary results of a multicenter, open label, phase II trial (M39037 TRIAL)},
  volume       = {100},
  year         = {2002},
}

Web of Science
Times cited: